Pogust Goodhead represents people suffering from vision-related issues after taking the prescription drug Elmiron (pentosan polysulfate sodium).
Elmiron, an FDA-approved medication used to treat Interstitial Cystitis, known as painful bladder syndrome, has been linked to pigmentary maculopathy (macular degeneration), toxicity, blindness, difficulty transitioning from light to dark, vision distortion, and other serious vision problems.
Elmiron contains PPS (pentosan polysulfate sodium), which can potentially cause toxic maculopathy, leading to permanent eye damage.
Despite this, Elmiron is being marketed as a treatment with only minor side effects. Studies show that this isn’t the case, and many people are suffering from irreversible damage to their vision.
We believe the manufacturer needs to be held accountable for this wrongdoing, and should compensate people like you who are suffering due to this negligence.
If you or a loved one is experiencing serious vision issues after taking Elmiron, please get in touch with us for a free consultation today.